Cardiomyopathies: MOGE(S): a standardized classification of cardiomyopathies?

Bongani M Mayosi1

  • 1Department of Medicine, J Floor, Old Groote Schuur Hospital, Groote Schuur Drive, Observatory, Cape Town 7925, South Africa.

Insights

The MOGE(S) classification offers a comprehensive approach to cardiomyopathy, integrating structural, functional, and genetic factors. This system aims for global acceptance but requires broad applicability across diverse healthcare settings.

Area of Science:

  • Cardiology
  • Genetics
  • Medical Classification Systems

Background:

  • Cardiomyopathy classification has undergone numerous revisions over six decades.
  • Existing systems may lack comprehensive integration of diverse etiological and clinical factors.

Purpose of the Study:

  • To introduce and evaluate the MOGE(S) classification system for cardiomyopathies.
  • To assess its potential for global adoption and applicability.

Main Methods:

  • The MOGE(S) system incorporates Monogenic, Organ involvement, Genomic, Environmental, and Structural/Functional assessments.
  • Evaluation criteria include comprehensiveness, clarity, and potential for universal implementation.

Main Results:

  • The MOGE(S) system provides a unified framework for describing cardiomyopathies.
  • It integrates key aspects including structural/functional abnormalities, organ involvement, genetics, etiology, and disease severity.

Conclusions:

  • The MOGE(S) classification represents a significant advancement towards a standardized global nomenclature for cardiomyopathies.
  • Further validation is needed to ensure its practical applicability in all healthcare systems worldwide.

Related Concept Videos

Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
826
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
805
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
952
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
790
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
753
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
1.0K